China · Delayed Price · Currency is CNY Beijing SL Pharmaceutical Statistics
Total Valuation
SHE:002038 has a market cap or net worth of CNY 7.02 billion. The enterprise value is 6.07 billion.
| Market Cap | 7.02B |
| Enterprise Value | 6.07B |
Important Dates
The next confirmed earnings date is Wednesday, April 29, 2026.
| Earnings Date | Apr 29, 2026 |
| Ex-Dividend Date | Jul 4, 2025 |
Share Statistics
SHE:002038 has 1.03 billion shares outstanding. The number of shares has decreased by -3.49% in one year.
| Current Share Class | 1.03B |
| Shares Outstanding | 1.03B |
| Shares Change (YoY) | -3.49% |
| Shares Change (QoQ) | -5.99% |
| Owned by Insiders (%) | 22.73% |
| Owned by Institutions (%) | 2.73% |
| Float | 634.08M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 11.25 |
| PB Ratio | 1.35 |
| P/TBV Ratio | 1.54 |
| P/FCF Ratio | 108.47 |
| P/OCF Ratio | 27.23 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 36.99, with an EV/FCF ratio of 93.84.
| EV / Earnings | -17.49 |
| EV / Sales | 9.73 |
| EV / EBITDA | 36.99 |
| EV / EBIT | n/a |
| EV / FCF | 93.84 |
Financial Position
The company has a current ratio of 2.87
| Current Ratio | 2.87 |
| Quick Ratio | 1.53 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -6.47% and return on invested capital (ROIC) is -0.06%.
| Return on Equity (ROE) | -6.47% |
| Return on Assets (ROA) | -0.03% |
| Return on Invested Capital (ROIC) | -0.06% |
| Return on Capital Employed (ROCE) | -0.05% |
| Weighted Average Cost of Capital (WACC) | 4.80% |
| Revenue Per Employee | 701,512 |
| Profits Per Employee | -390,549 |
| Employee Count | 889 |
| Asset Turnover | 0.10 |
| Inventory Turnover | 0.51 |
Taxes
In the past 12 months, SHE:002038 has paid 70.06 million in taxes.
| Income Tax | 70.06M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +4.81% in the last 52 weeks. The beta is 0.10, so SHE:002038's price volatility has been lower than the market average.
| Beta (5Y) | 0.10 |
| 52-Week Price Change | +4.81% |
| 50-Day Moving Average | 6.82 |
| 200-Day Moving Average | 7.45 |
| Relative Strength Index (RSI) | 42.68 |
| Average Volume (20 Days) | 117,000,682 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:002038 had revenue of CNY 623.64 million and -347.20 million in losses. Loss per share was -0.34.
| Revenue | 623.64M |
| Gross Profit | 387.56M |
| Operating Income | -2.65M |
| Pretax Income | -278.14M |
| Net Income | -347.20M |
| EBITDA | 164.13M |
| EBIT | -2.65M |
| Loss Per Share | -0.34 |
Balance Sheet
The company has 1.02 billion in cash and n/a in debt, with a net cash position of 1.02 billion or 0.99 per share.
| Cash & Cash Equivalents | 1.02B |
| Total Debt | n/a |
| Net Cash | 1.02B |
| Net Cash Per Share | 0.99 |
| Equity (Book Value) | 5.19B |
| Book Value Per Share | 5.17 |
| Working Capital | 1.36B |
Cash Flow
In the last 12 months, operating cash flow was 257.66 million and capital expenditures -192.97 million, giving a free cash flow of 64.69 million.
| Operating Cash Flow | 257.66M |
| Capital Expenditures | -192.97M |
| Depreciation & Amortization | 166.78M |
| Net Borrowing | n/a |
| Free Cash Flow | 64.69M |
| FCF Per Share | 0.06 |
Margins
Gross margin is 62.14%, with operating and profit margins of -0.42% and -55.67%.
| Gross Margin | 62.14% |
| Operating Margin | -0.42% |
| Pretax Margin | -44.60% |
| Profit Margin | -55.67% |
| EBITDA Margin | 26.32% |
| EBIT Margin | -0.42% |
| FCF Margin | 10.37% |
Dividends & Yields
This stock pays an annual dividend of 0.02, which amounts to a dividend yield of 0.29%.
| Dividend Per Share | 0.02 |
| Dividend Yield | 0.29% |
| Dividend Growth (YoY) | -86.67% |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 3.49% |
| Shareholder Yield | 3.78% |
| Earnings Yield | -4.95% |
| FCF Yield | 0.92% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on July 4, 2019. It was a forward split with a ratio of 1.5.
| Last Split Date | Jul 4, 2019 |
| Split Type | Forward |
| Split Ratio | 1.5 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |